In this study, we present a case of a patient diagnosed with aCML harboring ASXL1, SETBP1, and NRAS mutations, six years after the onset of eosinophilia. This evidence concerns the gene NRAS and atypical chronic myeloid leukemia, BCR-ABL1 negative.